BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 17407205)

  • 1. Report: EuroBioFund first annual forum in Helsinki.
    Biotechnol J; 2007 Apr; 2(4):406-7. PubMed ID: 17407205
    [No Abstract]   [Full Text] [Related]  

  • 2. Japanese council urges reform of funding system.
    Triendl R
    Nat Biotechnol; 2002 Dec; 20(12):1176-8. PubMed ID: 12454656
    [No Abstract]   [Full Text] [Related]  

  • 3. The changing norms of the life sciences.
    Shorett P; Rabinow P; Billings PR
    Nat Biotechnol; 2003 Feb; 21(2):123-5. PubMed ID: 12560827
    [No Abstract]   [Full Text] [Related]  

  • 4. European biotechnology turns East.
    Sansom C
    Nat Biotechnol; 1999 May; 17(5):437-9. PubMed ID: 10331797
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydrocarbons and renewable energy.
    Ringpfeil M
    Nat Biotechnol; 2004 Sep; 22(9):1077. PubMed ID: 15340466
    [No Abstract]   [Full Text] [Related]  

  • 6. Impossible fixes.
    Nat Biotechnol; 2010 Feb; 28(2):103. PubMed ID: 20139925
    [No Abstract]   [Full Text] [Related]  

  • 7. Taiwan: Biotech vision.
    Cyranoski D
    Nat Biotechnol; 2003 Apr; 21(4):463-4. PubMed ID: 12665831
    [No Abstract]   [Full Text] [Related]  

  • 8. Europe joins UK open-access bid.
    Van Noorden R
    Nature; 2012 Jul; 487(7407):285. PubMed ID: 22810672
    [No Abstract]   [Full Text] [Related]  

  • 9. Special: biotech in Russia.
    Rabinovich M; Burghardt N; Gorzka G; Kudryashev M; Leonov A; Konov A
    Biotechnol J; 2007 Jul; 2(7):775-89. PubMed ID: 17615597
    [No Abstract]   [Full Text] [Related]  

  • 10. European competition.
    Nat Mater; 2006 Nov; 5(11):839. PubMed ID: 17077838
    [No Abstract]   [Full Text] [Related]  

  • 11. More than the sum of their parts? Clustering is becoming more prevalent in the biosciences, despite concerns over the sustainability and economic effectiveness of science parks and hubs.
    Rinaldi A
    EMBO Rep; 2006 Feb; 7(2):133-6. PubMed ID: 16452923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotech firms jump on SARS bandwagon.
    Basu P
    Nat Biotechnol; 2003 Jul; 21(7):720. PubMed ID: 12833076
    [No Abstract]   [Full Text] [Related]  

  • 13. Biotechnological studies in the Far-Eastern Region of Russia.
    Stonik VA; Mikhailov VV; Bulgakov VP; Zhuravlev YN
    Biotechnol J; 2007 Jul; 2(7):818-25. PubMed ID: 17582826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corridor at the crossroads: Michigan.
    Smaglik P
    Nature; 2002 Nov; 420(6913):4-5. PubMed ID: 12447399
    [No Abstract]   [Full Text] [Related]  

  • 15. Reform science? First, reset the economy.
    Rosei F
    Nat Mater; 2006 Oct; 5(10):757-8. PubMed ID: 17013399
    [No Abstract]   [Full Text] [Related]  

  • 16. Little science, big bucks.
    DeFrancesco L
    Nat Biotechnol; 2003 Oct; 21(10):1127-9. PubMed ID: 14520387
    [No Abstract]   [Full Text] [Related]  

  • 17. Japan launches new life-science initiatives.
    Triendl R
    Nat Biotechnol; 2003 Mar; 21(3):218. PubMed ID: 12610556
    [No Abstract]   [Full Text] [Related]  

  • 18. How the EU can fund your company.
    Gilbert N
    Nat Biotechnol; 2007 Jan; 25(1):21-4. PubMed ID: 17294566
    [No Abstract]   [Full Text] [Related]  

  • 19. Italian science: greater expectations?
    Gambardella P
    Nat Mater; 2006 Oct; 5(10):757. PubMed ID: 17013400
    [No Abstract]   [Full Text] [Related]  

  • 20. Fertile grounds.
    Russo G
    Nature; 2009 Oct; 461(7268):1308-9. PubMed ID: 19998548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.